tirzepatide billings mt glp-1 billings mt Glucagon-Like Peptide-1 Based Therapies: A New Horizon in Obesity Management Tirzepatide in Billings, MT |

Treatments are overseen by Dr

Researchers reported modulation of numerous genes involved in tissue remodeling, inflammatory signaling, antioxidant responses, and extracellular matrix regulation

The effect of GLP-1 receptor agonists on epilepsy: no appetite for seizures

Participants lost an average of 16.6% of their body weight, a significant improvement compared to just 3.2% in the placebo group

Principal Scientist, Regeneron, Jay Caplan, President and Founder, Fractyl Health, Jerry Colca, Chief Scientific Officer, Cirius Therapeutics, Johan Fredrik Paulsson, Director Incretin and Amylin Biology, Novo Nordisk, Mina Sooch, Founder and General Partner, Apjohn Ventures, Scott Harris, Chief Medical Officer, Altimmune, Zohar Barbash, Chief Technology Officer, Lembas Bio Saturday, Aug 01, 2026 6:00p John F